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Abstract - In a clinical study of 49 patiellts with acute ischemic 
heart disease poor success rates from ventricular defibrillation 
were associated with a low dominant frequency of ventricular 
fibrillation (generally < 5 Hz) as determined by Fast Fourier 
Transform analysis of the body surface ECG. Experimental 
studies in the dog al/d pig are in accord with these 
observatiolls, al/d indicate that the dominant frequency of 
velltricular fibrillation is reduced both by a lollg duration of 
fibrillotioll in a 1I0rmai heart, alld by some causes of 
velltriculor fibrillation (ouabain or potassium toxicity in the 
dog, secolldary fibrillatioll ill mall). 
I. INTRODUCTION 
Despite total disorganization of cardiac 
mechanical activity the characteristic ECG trace of 
ventricular fibrillation shows a continuous waveform with 
variable amplitude. When analysed by the Fast Fourier 
Transform much of the power of the signal resides in low 
frequency components, with a strongly dominant narrow 
waveband [1-3]. Is this dominant frequency of any 
significance for clinical resuscitation? 
Since the introduction of cardiac defibrillation to 
clinical practice by Kouwenhoven, Beck, Zoll, Lown and 
their colleagues [4] considerable attention has focussed on 
improving the success rate for ventricular defibrillation. 
Various factors have been shown to be important, 
including the avoidance of delay in defibrillation, 
correction of acidosis, the maintenance of circulation by 
carsliac massage, and the amplitUde of the ECG signal of 
ventricular fibrillation [5,6]. 
II. EXPERIMENTAL STUDIES 
The first experiments were undertaken in 
greyhound dogs (21-35 kg) anesthetized with sodium 
pentobarbitone (30 mg/kg iv) and ventilated with room air 
[7]. The dominant frequency of the ECG at the body 
surface (Lead II) was 9.9 ± 0.7 Hz (mean ± S.E.M.), 
and fell with time, decreasing to 4 - 5 Hz after 90 - 120 
seconds of fibrillation. There was no early decline in 
fibrillation frequency in the endocardium [8]. Similar 
results were found for spontaneous and induced 
fibrillation during acute myocardial ischemia. However 
with fibrillation induced by toxic doses of ouabain (7.1 ± 
0-7803-0785-2/92$03.00 ©IEEE 
1.1 Hz) and by the administration of potassium (4.8 ± 
0.8 Hz) the frequency of fibrillation was significantly 
reduced. Clinically these 2 situations cause ventricular 
fibrillation which is difficult to abolish. 
With continued ventricular fibrillation for 90 
seconds the success rates for defibrillation with a 50 Joule 
shock were decreased in a further study, compared with 
those for short - duration fibrillation « 10 seconds). 
Higher stored energies did not increase the defibrillation 
success rate. 
Similar studies were undertaken in pigs (30-45 
kg) anesthetized with azaperone and pentobarbitone (30 
mglkg). The dominant frequency of fibrillation induced 
by electrical stimulation of the right ventricular 
endocardium was similar (11.1 ± 0.5 Hz; 13 pigs, 33.5 
+ 1.1 kg weight) to that in the dogs, and showed a 
progressive fall with duration of fibrillation greater than 
5 mins (4.3 ± 0.4 Hz at 10 mins). However, in contrast 
with the dogs, the fibrillation frequency showed a similar 
frequency and time-course in the endocardium and at the 
body surface throughout the period of observation. 
III. CLINICAL STUDIES 
What happens during ventricular fibrillation in 
man? Fast Fourier transform analysis of the ECG 
recordings of the first 8 seconds of ventricular fibrillation 
was undertaken in 49 patients (Bruel and Kjaer spectrum 
analyser). These patients were under observation prior to 
the onset of ventricular fibrillation, either in the Mobile 
Coronary Care Unit or in the hospital Coronary Care 
Unit. The body surface ECG was continuously digitized 
(10 bits and 240 Hz) with an anti-aliasing filter (44 Hz), 
recorded on magnetic tape during fibrillation and 
resuscitation, and later analyzed. 
The dominant frequency of ventricular fibrillation 
(VF) was significantly higher in the primary VF group 
(5.18 ± 0.3 Hz; 33 patients) when compared with the 
secondary VF group (3.95 ± 0.3 Hz; 16 patients; p < 
0.05). 
The resuscitation success rate was also higher in 
the primary VF group (20 of 33; 60.6%) compared with 
the secondary VF group (4 of 16; 25%; P < 0.05). 
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In the primary VF group, when the dominant 
frequency of VF was above 5 Hz (n=20) the resuscitation 
success was 95%, but only 7.7% when the dominant 
frequency was 5 Hz or below ( n= 13 ). In this group of 
13 patients, with a low frequency of fibrillation, the 
dominant frequency of VF was highly correlated with the 
estimated duration of ventricular fibrillation ( r = -0.78; P 
< 0.05). 
IV. CONCLUSIONS 
Hence a decrease in the success of clinical 
defibrillation was observed when the frequency of VF was 
5 Hz or less. Together the clinical and experimental data 
suggest that myocardial deterioration can be assessed by 
frequency analysis of ventricular fibrillation. Whether 
fibrillation frequency is a primary factor in poor 
resuscitation success, or an indicator of adverse 
electrophysiological and metabolic conditions in the 
myocardium remains to be established. 
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